drugset / Trial / NCT06955741
A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess drug levels, tolerability and absolute biological availability of single subcutaneous dose of BMS-986446 in healthy participants
Timeline
- Start
- 2025-05-05
- Primary completion
- 2025-09-11
- Completion
- 2025-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986446 | Monoclonal antibody | — | Intravenous |
| Background | Acetaminophen | Small molecule | — | — |
| Background | Loratadine | Small molecule | — | — |
Indications
No indication recorded.